Characteristics and outcomes of real-world patients with microsatellite instability-high solid tumors treated with pembrolizumab monotherapy after FDA approval

Snow, T, Swaminathan, A, Snider, J, Schrock, AB, Li, G, Alexander, BM, Singal, G, Castellanos, EH, McCusker, M

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

Association of BRCA alteration type with real-world outcomes to PARP inhibitors in patients with metastatic castrate-resistant prostate cancer

Antonarakis, ES, Madison, RW, Snider, J, Snow, T, Sokol, ES, Chung, JH, McCusker, M, Singal, G, Alexander, BM, Castellanos, EH, Venstrom, JM, Schrock, AB, Ross, JS

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

An automated EHR-based tool for identification of patients with metastatic disease to facilitate clinical trial patient ascertainment

Kirshner, J, Cohn, K, Dunder, Steven, Donahue, K, Richey, MM, Larson, PD, Sutton, LM, Siu, E, Donegan, J, Chen, Z, Nightingale, C, Hamrick, HJ

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

Use of real-world data to understand barriers to interventional clinical trial enrollment in community oncology clinics

Blakely, J, Gordon, L, Schwartzberg, L, Gutman, J, Adamson, BJS, Bourla, AB, Meropol, NJ, Ramsey, SD, Green, RJ

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

A multi-stakeholder platform to prospectively link longitudinal real-world clinico-genomic, imaging, and outcomes data for patients with metastatic lung cancer

Lu, MW, Walia, G, Schulze, K, Doral, MY, Maund, SL, Gaffey, S, Cabili, MN, Bourla, AB, Green, RJ, Santos, EC, Herbst, RS, Chiang, AC, Schwartzberg, L

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

The adoption of immune checkpoint inhibitors and patterns of care at the end of life

Riaz, F, Gan, G, Li, F, Davidoff, AJ, Adelson, KB, Presley, CJ, Adamson, BJS, Shaw, P, Parikh, RB, Mamtani, R, Gross, CP

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

Real-world outcomes for advanced non-small cell lung cancer patients with EGFR exon 19 deletions stratified by deletion size

Ou, SI, Madison, RW, Snow, T, Snider, J, McCusker, M, Singal, G, Alexander, BM, Venstrom, JM, Castellanos, EH, Schrock, AB

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

Real-world ALK testing compliance to NCCN guideline and factors of underutilization

Bernicker, E, Xiao, Y, Abraham, A, Engstrom-Melnyk, J, Croix, D, Yang, B, Shah, RA, Madala, J, Allen, T

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

Real-world outcomes of patients with BRAF-mutated mCRC treated in the United States

Braithwaite, M, Nevala-Plagemann, C, Baron, K, Halland, B, Garrido-Laguna, I, Pappas, LM, Moser, JC

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

Real-world outcomes after second-line treatment in non-small cell lung cancer patients treated with immunotherapy

Marmarelis, ME, Hwang, W-T, Yang, Y-X, Ciunci, C, Singh, A, Aggarwal, C, Cohen, RB, Langer, CJ, Mamtani, R, Bauml, JM

May 2020

Abstract

ASCO Annual Meeting

Prevalence of ALK mutation in advanced NSCLC patients in the United States

Allen, T, Xiao, Y, Abraham, A, Redpath, S, Engstrom-Melnyk, J, Croix, D, Yang, B, Shah, RA, Madala, J, Bernicker, E

May 2020

Abstract

ASCO Annual Meeting

Uptake of targeted therapy in clinical practice among US patients with ovarian cancer

Chan, J, Meyer, L, Luhn, P, Flores, C, Bastere-Truchot, L, Downer, MK, Lin, YG, Wright, JD

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

Indirect comparison of TAK-788 vs real-world data outcomes in refractory non-small cell lung cancer with EGFR exon 20 insertions

Horn, L, Lin, HM, Padda, SK, Aggarwal, C, McCoach, CE, Zhu, Y, Yin, Y, Li, S, Feng, Z, Neal, JW

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

Real-world treatment patterns and clinical outcomes of advanced melanoma patients following disease progression on anti-PD-1-based therapy

Hernandez-Aya, LF, Burke, M, Collins, JM, Earle, D, Hamilton, M, Nordstrom, BL, Zhang, Y, Srivastava, S

May 2020

Abstract

ASCO Annual Meeting

Uptake of first-line immune checkpoint inhibitors among medically frail patients with advanced solid malignancies

Parikh, RB, Cohen, RB, Min, EJ, Wileyto, EP, Riaz, F, Gross, CP, Long, Q, Mamtani, R

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

Overall survival in Non-small cell lung cancer patients with comorbidities treated with frontline chemotherapy or immunotherapy: a real-world data collaboration

Rivera, DR, Lasiter, L, Christian, JB, Enewold, L, Espirito, JL, Hansen, E, Henk, HJ, Kushi, L, Lane, D, Natanzon, Y, Benito, RP, Rasmussen, E, Robert, NJ, Stewart, M, Sweetnam, C, Tymejczyk, O, Valice, E, Wagner, J, Zander, A, Allen, J

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

April 2020

Manuscript

PLoS One

Flatiron-authored

April 2020

Manuscript

ESMO Open

April 2020

Manuscript

Clinical Lung Cancer

Flatiron-authored

Primary tumor location and survival in colorectal cancer: A retrospective cohort study

Aggarwal, H, Sheffield, KM, Li, L, Lenis, D, Sorg, RA, Barzi, A, Miksad, RA

April 2020

Manuscript

World Journal of Gastrointestinal Oncology

Flatiron-authored

April 2020

Manuscript

Lung Cancer

April 2020

Manuscript

Cancer Discovery

Flatiron-authored

March 2020

Manuscript

medRxiv

Flatiron-authored

Quality measurement in cancer care: A review and endorsement of high-impact measures and concepts

D'Amico, TA, Bandini, L, Balch, A, Benson III, AI, Edge, SB, Fitzgerald, L, Green, RJ, Koh, W, Kolodziej, MA, Kumar, S, Meropol, NJ, Mohler, JL, Pfister, D, Walters, RS, Carlson, RW

March 2020

Manuscript

JNCCN

Flatiron-authored

Author’s response to ‘‘A Letter in Support of Real-World RECIST’’

Griffith, SD, Tucker, MG, Bowser, B, Calkins, G, Chang, C, Guardino, E, Khozin, S, Kraut, J, You, P, Schrag, D, Miksad, RA

February 2020

Manuscript

Advances in Therapy

Flatiron-authored

Real-world dosing patterns and outcomes of patients with metastatic pancreatic cancer treated with a liposomal irinotecan regimen in the United States

Barzi, A, Miksad, RA, Surinach, A, Corvino, FA, Wang, S, Torres, AZ, Mamlouk, K, Pulgar, S, Valderrama, A, Bekaii-Saab, T, Ahn, D

January 2020

Manuscript

Pancreas

Flatiron-authored

Assessing real-world biomarker testing rates in metastatic colon cancer

Nakhoda, S, Deng, M, Iyer, P, Handorf, E, Jain, R, Meropol, NJ, Dotan, E

January 2020

Abstract

ASCO GI Symposium

Flatiron-authored

January 2020

Abstract

ASCO GI Symposium

Flatiron-authored

January 2020

Abstract

ASCO GI Symposium

January 2020

Abstract

ASCO GI Symposium